Literature DB >> 35070400

A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer.

Xu Wang1, Qijin He1, Huixi Liang1, Jiani Liu1, Xin Xu1, Kui Jiang1, Jie Zhang1.   

Abstract

BACKGROUND: Accurate assessment of lymph node status in gastric cancer (GC) patients can help to select appropriate treatment strategies for GC, but the diagnostic accuracy of conventional methods needs to be improved. The aim of this study was to investigate the predictive value of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) on lymph node status in GC patients and to construct a risk prediction model.
METHODS: This study retrospectively analyzed the clinicopathological characteristics of 349 patients with GC who underwent radical gastrectomy, among which 250 patients were recruited in the training cohort and 99 patients in the independent validation cohort. Significant risk factors in univariate analysis were further identified as independent variables in multivariate logistic regression analysis, which were then incorporated and presented in a nomogram. Receiver operating characteristic (ROC) curves, Calibration curve and decision curve analysis (DCA) curves were used to evaluate the discrimination, prediction accuracy and clinical effectiveness of the model.
RESULTS: Multifactorial logistic regression analysis showed that alcohol use (OR =2.203, P=0.036), Depth of invasion (OR =7.756, P<0.001), differentiation (OR =2.252, P=0.018), carcinoembryonic antigen (CEA) (OR =2.443, P=0.017), carbohydrate antigen 19-9 (CA199) (OR =2.715, P=0.008) and HALP (OR =2.276, P=0.032) were independent risk factors for lymph node metastasis (LNM) in GC. We used these factors to construct a nomogram for predicting LNM in GC patients, and the ROC curves showed good discrimination of the model with AUC values of 0.854 (training cohort) and 0.868 (validation cohort), respectively, and the calibration curves showed good predictive ability of the nomogram, in addition to the DCA curves results showed the clinical usefulness of the model.
CONCLUSIONS: In conclusion, we established a nomogram for predicting LNM in patients with GC. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Gastric cancer (GC); lymph node metastasis (LNM); nomogram; risk factors

Year:  2021        PMID: 35070400      PMCID: PMC8748024          DOI: 10.21037/jgo-21-507

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  38 in total

Review 1.  Hypoalbuminemia and Clinical Outcomes: What is the Mechanism behind the Relationship?

Authors:  Sunghye Kim; Stephen A McClave; Robert G Martindale; Keith R Miller; Ryan T Hurt
Journal:  Am Surg       Date:  2017-11-01       Impact factor: 0.688

2.  Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer.

Authors:  Milana Sachlova; Ondrej Majek; Stepan Tucek
Journal:  Nutr Cancer       Date:  2014-10-30       Impact factor: 2.900

Review 3.  The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis.

Authors:  Mohamed M Abdelfatah; Mohamed Barakat; Hyuk Lee; Jae J Kim; Noriya Uedo; Ian Grimm; Mohamed O Othman
Journal:  Gastrointest Endosc       Date:  2017-09-28       Impact factor: 9.427

Review 4.  Early gastric cancer: an update on endoscopic management.

Authors:  Veronica Baptista; Anupam Singh; Wahid Wassef
Journal:  Curr Opin Gastroenterol       Date:  2012-11       Impact factor: 3.287

5.  Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer.

Authors:  Wenyang Pang; Neng Lou; Cancan Jin; Changyuan Hu; Chandoo Arvine; Guangbao Zhu; Xian Shen
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-05       Impact factor: 2.566

6.  Nomogram analysis and external validation to predict the risk of lymph node metastasis in gastric cancer.

Authors:  Shi Chen; Run-Cong Nie; Li-Ying OuYang; Yuan-Fang Li; Jun Xiang; Zhi-Wei Zhou; YingBo Chen; Jun-Sheng Peng
Journal:  Oncotarget       Date:  2017-02-14

7.  The Role of the Lymph Node Ratio in Advanced Gastric Cancer After Neoadjuvant Chemotherapy.

Authors:  Karol Rawicz-Pruszyński; Bogumiła Ciseł; Radosław Mlak; Jerzy Mielko; Magdalena Skórzewska; Magdalena Kwietniewska; Agnieszka Pikuła; Katarzyna Gęca; Katarzyna Sędłak; Andrzej Kurylcio; Wojciech P Polkowski
Journal:  Cancers (Basel)       Date:  2019-12-01       Impact factor: 6.639

Review 8.  Targeting cellular metabolism to improve cancer therapeutics.

Authors:  Y Zhao; E B Butler; M Tan
Journal:  Cell Death Dis       Date:  2013-03-07       Impact factor: 8.469

9.  Validation of Six Nomograms for Predicting Non-sentinel Lymph Node Metastases in a Dutch Breast Cancer Population.

Authors:  Siem A Dingemans; Peter D de Rooij; Roos M van der Vuurst de Vries; Leo M Budel; Caroline M Contant; Anne E M van der Pool
Journal:  Ann Surg Oncol       Date:  2015-09-14       Impact factor: 5.344

View more
  2 in total

1.  Machine learning for lymph node metastasis prediction of in patients with gastric cancer: A systematic review and meta-analysis.

Authors:  Yilin Li; Fengjiao Xie; Qin Xiong; Honglin Lei; Peimin Feng
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

2.  Model based on preoperative clinical characteristics to predict lymph node metastasis in patients with gastric cancer.

Authors:  Baicheng Ding; Panquan Luo; Jiahui Yong
Journal:  Front Surg       Date:  2022-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.